Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

343 Views

Poster Session: Pediatric Viral Studies

2161 - Posoleucel, an Allogeneic, Off-the-Shelf Multi-Virus Specific T Cell Therapy, for Severe, Drug-Refractory Viral Infections in Pediatric Patients Following HCT: Results from a Phase 2 Trial

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

TP

Thomas Pfeiffer, MD

St. Jude Children's Research Hospital
Memphis, Tennessee, United States
IT

Ifigeneia Tzannou, MD

Baylor College of Medicine, Texas Children’s Hospital
Houston, Texas, United States
CR

Carlos Ramos, MD

Baylor College of Medicine
Houston, Texas, United States
GS

Ghadir Sasa, MD

Baylor College of Medicine, Texas Children’s Hospital
houston, Texas, United States
CM

Caridad Martinez, MD

Baylor College of Medicine, Texas Children’s Hospital
Houston, Texas, United States
PL

Premal Lulla, MBBS

Baylor College of Medicine
Houston, Texas, United States
RK

Robert Krance, MD

Baylor College of Medicine
Houston, Texas, United States
SN

Swati Naik, MD

St. Jude Children's Research Hospital
Memphis, Tennessee, United States

Presenting Author(s)

Iain Fraser, MD, DPhil (he/him/his)

Clinical Fellow
AlloVir
Waltham, Massachusetts, United States

Co-Author(s)

MW

Marshelle Warren, MD

Glacier Bio
North Bend, Washington, United States
BP

Badrish Patel, MD

AlloVir
Waltham, Massachusetts, United States
DW

Dany Ward, RN

AlloVir
Waltham, Massachusetts, United States
AL

Ann Leen, PhD

Baylor College of Medicine
Houston, Texas, United States
BO

Bilal Omer, MD

Baylor College of Medicine
Houston, Texas, United States